Stereotaxis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Stereotaxis, Inc. on April 30, 2010. The report discloses the entry into a material definitive agreement with Biosense Webster, Inc.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a contractual amendment rather than financial performance data.
Material Changes
On April 30, 2010, the Company entered into a Fourth Amendment to the Development Alliance and Supply Agreement with Biosense Webster, Inc. Key changes include:
- Extension of Biosense Webster's exclusive distribution rights for the Company's non-irrigated catheters until August 1, 2010.
- Update to the revenue sharing arrangement to align with the extended term.
Outlook, Risks, and Management Commentary
The primary purpose of the extension is to provide additional time for negotiations regarding a possible expanded collaboration agreement. This potential new agreement may include co-marketing of Odyssey products. The filing does not disclose specific risks, contingencies, or unusual items beyond the terms of this amendment.
Investor Verification Checklist
- Verify the status of negotiations for the expanded collaboration agreement and co-marketing of Odyssey products.
- Confirm the specific terms of the updated revenue sharing arrangement.
- Monitor whether the exclusive distribution rights are renewed or modified after the August 1, 2010 deadline.